Paydirt
NTLA
Ticker

Intellia Therapeutics, Inc.

NTLA · Healthcare · Intellia Therapeutics, Inc. operates as a clinical-stage genome editing company focused on developing potentially curative therapeutics usi…

Intellia Therapeutics, Inc. (NTLA), in the Healthcare sector, has 5 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 1 purchase and 4 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Aug 20 and filed Aug 24. The most active filer was John M Leonard with 4 filings.

Add to watchlist
Filings, ttm
5
1 buy · 4 sells
Traders, ttm
3
3 insiders
Volume, ttmiDollar value disclosed in the window
$2.9M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Aug 20
Filed Aug 24
ADViAverage daily dollar volume
$62.4M
market data
Share price · 12M
$12.87 (-25.4%)
$27.98$18.01$8.04Sep 22 2025Mar 12Aug 28

Adjusted for splits and dividends.

Volume by month
$1.4M$701K$0Oct 2024Apr 2025Oct 2025Apr 2026Jan 2025 · sells $552KJul 2025 · sells $105KAug 2025 · buys $1.0MDec 2025 · sells $785KJan 2026 · buys $1.4MJan 2026 · sells $424KAug 2026 · sells $251K
Buys $2.4M Sells $2.1M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed
JL John M Leonard President and CEO 4 filings DL David Lebwohl EVP, Chief Medical Officer 2 filings WC William J Chase Director 1 filing FC Fred E Cohen Director 1 filing EI Edward J Dulac III EVP, Chief Financial Officer 1 filing LL Laura Sepp-Lorenzino EVP, Chief Scientific Officer 1 filing
Recent filings
John M LeonardSALE President and CEO $251K
19,890 sh × $12.60
Exec Aug 20
Filed Aug 24 · 4:05 PM ET David LebwohlSALE EVP, Chief Medical Officer $110K
11,903 sh × $9.21
Exec Jan 5
Filed Jan 7 · 5:30 PM ET John M LeonardSALE President and CEO $314K
34,146 sh × $9.21
Exec Jan 5
Filed Jan 7 · 5:30 PM ET Fred E CohenPURCHASE Director $1.4M
150,000 sh × $9.35
Exec Jan 5
Filed Jan 7 · 4:05 PM ET John M LeonardSALE President and CEO $785K
82,791 sh across 2 lots
Exec Dec 11 2025
Filed Dec 12 2025 · 5:30 PM ET William J ChasePURCHASE Director $1.0M
100,000 sh × $10.03
Exec Aug 20 2025
Filed Aug 22 2025 · 4:30 PM ET Edward J Dulac IIISALE EVP, Chief Financial Officer $105K
7,462 sh × $14.02
Exec Jul 23 2025
Filed Jul 25 2025 · 5:30 PM ET Laura Sepp-LorenzinoSALE EVP, Chief Scientific Officer $109K
8,966 sh × $12.18
Exec Jan 3 2025
Filed Jan 7 2025 · 5:30 PM ET John M LeonardSALE President and CEO $327K
26,807 sh × $12.18
Exec Jan 3 2025
Filed Jan 7 2025 · 5:30 PM ET David LebwohlSALE EVP, Chief Medical Officer $116K
9,557 sh × $12.18
Exec Jan 3 2025
Filed Jan 7 2025 · 5:30 PM ET